Honda Motor Extends Suspension of Some China Production After Job Cuts
By Megumi Fujikawa
TOKYO--Honda Motor plans to continue suspending some production at its Chinese joint venture with Dongfeng Motor Group following its decision to reduce headcount in the world's largest car market as part of a broader strategy shift.
The Japanese automaker is set to resume production at two of Dongfeng Honda's three plants in China on Thursday after a suspension on Aug. 26 to reduce inventory, a Honda spokeswoman said.
Production at the other plant will remain halted until Sept. 22, as the company cut jobs by offering voluntary retirement packages in late August, the spokeswoman said.
Chinese media reported that the job cuts would affect about 2,000 workers. Honda declined to disclose the size of the reduction.
The moves came as sales of Honda cars, which mostly run on gasoline or hybrid engines, are struggling in China as consumers there shift toward electric vehicles.
In a statement on social media on Tuesday, Dongfeng Honda called the layoffs a strategic adjustment to ensure its sustainable operation and pivot to EVs.
The three Chinese factories have a combined annual capacity of 720,000 vehicles.
Shares in Honda ended 3.0% lower on Wednesday.
Write to Megumi Fujikawa at megumi.fujikawa@wsj.com
(END) Dow Jones Newswires
September 11, 2024 05:26 ET (09:26 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks